Peng et al. reported that treatment with an inhibitor of EZH2 together with an inhibitor of DNA methyltransferase 1 (DNMT1) led to better tumor growth suppression than either approach alone in ovarian tumor-bearing mice [10, 11]. The gene discussed is EZH2; the disease is neoplasm.